Mesa Biotech to Present Research at Association for Molecular Pathology 2017 Annual MeetingBy: Mesa Biotech SAN DIEGO - Nov. 1, 2017 - PRLog -- Mesa Biotech, Inc., a privately-held, molecular diagnostic company that has developed an affordable PCR testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced that it will present original research at the annual Association for Molecular Pathology (AMP) meeting, being held November 16 – 18, 2017 at the Calvin L. Rampton Salt Palace Convention Center in Salt Lake City, Utah.
Presentation Title: Comparison of the Accula™ Influenza A/B PCR Assay and Alere™ Influenza A/B Isotherm Amplification Assay for the Detection of Influenza in Adult and Pediatric Populations Speaker: Dr. Steve Young, Director of Research and Clinical Trials, TriCore Reference Laboratory Time: November 18, 9:45 am – 10:45 am Place: Exhibit Hall Poster Number: ID25 "Our new technology aligns nicely with this year's AMP Conference theme 'Where Molecular Leads Medicine to Best Patient Care," said Dr. Hong Cai, Co-founder and Chief Executive Officer, Mesa Biotech, Inc. "We are excited to present our latest findings and research affirming the value of our first molecular PCR assay for use at the point of care for enhanced patient care." The AMP conference is a four-day event attended by clinical practitioners/ About Mesa Biotech Inc. Mesa Biotech designs, develops and manufactures next generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the point-of-care (POC). Mesa Biotech's Accula™ System consists of a portable, palm-sized dock and a disposable, assay-specific test cassette. This patented system will allow healthcare professionals to access actionable, laboratory-quality results at the POC with greater sensitivity and specificity than current infectious disease rapid immunodiagnostic tests. Mesa Biotech's technology development has been funded to date by a series of grants and private equity investments. For more information visit http://www.mesabiotech.com. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|